EXPLANATORY NOTE
(This note is not part of the Regulations)
These Regulations amend Regulations relating to the making and recovery of charges in relation to the supply of drugs and the provision of treatment as part of the health service in Northern Ireland, so as to enable the provision of treatment in relation to pandemic influenza without charge.
Regulation 2 amends the Charges for Drugs and Appliances Regulations (Northern Ireland) 1997 which make provision for charges for the supply of drugs and appliances under the Health and Personal Social Services (Northern Ireland) Order 1972. The amendment provides that no charge shall be made by the Regional Board or an HSC trust when there is a pandemic disease (such as pandemic influenza) which poses a serious risk, or potentially poses a serious risk, to human health (or such a disease is anticipated imminently) and the supply of the drug is in accordance with a protocol relating to that disease as provided for in Article 12F of the Prescription Only Medicines (Human Use) Order 1997 or Article 8 of the Medicines (Pharmacy and General Sale—Exemption) Order 1980.
Regulation 3 amends the Provision of Health Services to Persons not Ordinarily Resident Regulations (Northern Ireland) 2005 (“the 2005 Regulations”) which make provision as to the entitlement of, and exemption from charges for, services forming part of health services which may be provided to visitors to Northern Ireland. Regulation 4(5)(d) of the 2005 Regulations provides that no charge shall be made in respect of services forming part of the health service that are provided for a visitor for treatment in respect of a disease listed in Schedule 1 to the 2005 Regulations. Regulation 3 of these Regulations amends that Schedule to insert an entry for pandemic influenza. The effect is that a visitor who is being treated in a hospital for pandemic influenza will be exempt from charges for any Health Service treatment in respect of that condition.
A full regulatory impact assessment has not been produced for this instrument as it has no impact on the private and voluntary sectors.